Lactams
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2642 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 29 | 51 | 98 | 168 | 112 | 441 |
| Healthy volunteers/patients | — | — | — | 183 | 4 | 4 | 8 | 17 | 212 |
| Communicable diseases | D003141 | — | — | 8 | 22 | 50 | 58 | 44 | 179 |
| Pneumonia | D011014 | EFO_0003106 | J18 | 14 | 21 | 49 | 38 | 36 | 149 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 33 | 53 | 23 | 1 | 14 | 110 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 25 | 42 | 24 | 11 | 13 | 108 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 4 | 23 | 39 | 21 | 13 | 96 |
| Bacterial infections | D001424 | — | A49 | 30 | 9 | 15 | 20 | 22 | 94 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 7 | 10 | 23 | 26 | 34 | 94 |
| Helicobacter infections | D016481 | EFO_1000961 | — | 4 | 9 | 20 | 39 | 24 | 92 |
Show 320 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 8 | 8 | 6 | — | 4 | 24 |
| Recurrence | D012008 | — | — | 5 | 8 | 3 | — | 2 | 16 |
| Multiple myeloma | D009101 | — | C90.0 | 4 | 4 | 3 | — | 2 | 11 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 5 | 4 | 3 | — | — | 9 |
| Aids-related opportunistic infections | D017088 | — | — | — | — | 1 | — | 7 | 8 |
| Bacterial skin diseases | D017192 | — | — | — | — | 7 | — | — | 7 |
| Meningeal tuberculosis | D014390 | — | A17.0 | 1 | 6 | 2 | — | — | 7 |
| Gram-positive bacterial infections | D016908 | — | — | 1 | 3 | 2 | — | 2 | 7 |
| Colorectal neoplasms | D015179 | — | — | 2 | 5 | 1 | — | 1 | 7 |
| Covid-19 | D000086382 | — | U07.1 | 1 | 1 | 3 | — | 2 | 6 |
Show 139 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 8 | 5 | — | — | — | 12 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 5 | 5 | — | — | 2 | 10 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 4 | 6 | — | — | — | 7 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 2 | — | — | 3 | 5 |
| Lung neoplasms | D008175 | — | C34.90 | 2 | 4 | — | — | — | 5 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 3 | 2 | — | — | — | 5 |
| Carcinoma | D002277 | — | C80.0 | — | 5 | — | — | — | 5 |
| Triple negative breast neoplasms | D064726 | — | — | 2 | 2 | — | — | — | 4 |
| Melanoma | D008545 | — | — | 2 | 2 | — | — | — | 4 |
| Sarcoma | D012509 | — | — | 2 | 2 | — | — | — | 4 |
Show 128 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics | D010599 | — | — | 11 | — | — | — | 6 | 17 |
| Acute-on-chronic liver failure | D065290 | — | — | 1 | — | — | — | 4 | 5 |
| Gastrointestinal diseases | D005767 | — | — | 1 | — | — | — | 4 | 5 |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | 1 | — | — | — | 4 | 5 |
| Aids-related complex | D000386 | EFO_0007137 | B20 | 1 | — | — | — | 3 | 4 |
| Primary myelofibrosis | D055728 | — | D47.4 | 3 | — | — | — | — | 3 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 2 | — | — | — | 1 | 3 |
| Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | 2 | 3 |
| Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | 2 | — | — | — | 1 | 3 |
| Respiration disorders | D012120 | — | J00-J99 | 2 | — | — | — | 1 | 3 |
Show 60 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug monitoring | D016903 | — | — | — | — | — | — | 6 | 6 |
| Kwashiorkor | D007732 | EFO_1001009 | E40 | — | — | — | — | 4 | 4 |
| Sleep initiation and maintenance disorders | D007319 | — | F51.01 | — | — | — | — | 3 | 3 |
| Critical care | D003422 | — | — | — | — | — | — | 3 | 3 |
| Peritonsillar abscess | D000039 | EFO_0007429 | J36 | — | — | — | — | 3 | 3 |
| End stage liver disease | D058625 | EFO_1001311 | K72.1 | — | — | — | — | 3 | 3 |
| Hysterectomy | D007044 | EFO_0003881 | — | — | — | — | — | 3 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
| Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 2 | 2 |
| Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 2 | 2 |
Show 169 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use